Tumor cells grown on 3-d laminin-rich ECM cultures were radiosensitive to dual-targeted treatment with AIIB2 (targeting ITGB1)/imatinib (targeting c-Abl, a tyrosine kinase), which also significantly reduced DNA damage repair in head and neck cancer cells [145]. This evidence concerns the gene ITGB1 and head and neck cancer.